Search Results 1501-1510 of 21387 for platelets

1. THA Lumbar Plexus Verses Periarticular - Clinical Trials

   Contraindication to a regional anesthesia technique (e.g., preexisting neuropathy in the operative extremity, coagulopathy [platelets < 100,000, INR >1.5], ...

2. IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome - Mayo Clinic

   Platelets > 10 x 10^9/L; ECOG performance status of 0, 1 or 2; Prior systemic chemotherapy, immunotherapy, or biological therapy, radiation therapy and/or ...

3. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

   Platelets < 100,000/mm3 [100 x 109/L]; Hemoglobin < 9.0 g/dL; Serum creatinine >1.5 x ULN or calculated or directly measured CrCl < 50% LLN (lower limit of ...

4. Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes - Mayo Clinic

   Platelet count at least 100,000/mm^3. Hepatic: Bilirubin no greater than 1.5 mg/dL. SGOT no greater than 2 times upper limit of normal. Renal: Creatinine no ...

5. Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study - Mayo Clinic

   Coagulation disorders (platelets < 100,000, PT > 2 seconds above control or INR > 1.5); Anemia (Hemoglobin <11.0 g/dL in women and <12.5 g/dL in men); Liver ...

6. A Study to Evaluate Rivaroxaban to Reduce Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients with Acute COVID-19 Infection - Mayo Clinic

   known severe thrombocytopenia (platelet count <50 x 10^9/L); or; active cancer and undergoing treatment. Any illness or condition that in the opinion of the ...

7. Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients with Newly Diagnosed Ependymoma - Mayo Clinic

   Platelet count ≥ 100,000/μL (transfusion independent); Creatinine clearance or radioisotope GFR ≥ 70 mL/min OR serum creatinine based on age/gender as ...

8. DeeDee Stiepan | Mayo Clinic News Network - Page 8 of 25

   With the constant need for blood and platelet donations, frequent, regular blood donors are crucial to having a continuous national blood supply. Across ...

9. Study Evaluating The Safety And Efficacy Of Semaglutide, And The Fixed-Dose Combination Of Cilofexor And Firsocostat, Alone And In Combination, In Participants With Compensated Cirrhosis (F4) Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

   - Platelet count ≥ 125,000/uL; - Alanine Aminotransferase (ALT) < 5 x ULN; - Serum albumin ≥ 3.5 g/dL; - Serum Alkaline Phosphatase (ALP) ≤ 2 x ULN ...

10. A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis - Mayo Clinic

    Platelet count < 50 x 10e9/L, OR; Hgb < 100 g/L, have received ≥ 2 units PRBC in the 12 weeks prior to study entry, and be intolerant of or had inadequate ...